Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 10 2016

First Edition: October 10, 2016

Today's early morning highlights from the major news organizations.

California Healthline: In For A Shock: Exchange Customers Get Glimpse Of Painful Rate Hikes

Covered California’s big 2017 rate hikes are starting to hit home for consumers. The state health insurance exchange began mailing notices to its 1.3 million customers on Wednesday, alerting them that they can determine exactly how much the premiums for their current plans will rise in 2017, and begin shopping around for cheaper options. (Bazar, 10/7)

The New York Times: Mylan To Settle EpiPen Overpricing Case For $465 Million

Mylan, the maker of the allergy treatment EpiPen, said Friday that it had reached a $465 million settlement with the Justice Department and other government agencies over questions on whether the company had overcharged Medicaid for the treatment by improperly classifying it as a generic drug. The federal government said this week that Mylan had been told multiple times that it was wrongly classifying the EpiPen, which led the Medicaid and Medicare programs to overpay for the product. (Thomas, 10/7)

NPR: EpiPen-Maker Mylan Settles For $465 Million In Medicaid Dispute

Drugmaker Mylan N.V. announced Friday that it had reached a $465 million settlement with the U.S. Justice Department and other government agencies to resolve questions over rebates required by the Medicaid program. The deal settles allegations by the Centers for Medicare and Medicaid Services that Mylan had misclassified the EpiPen as a generic drug and had not paid the appropriate rebates that are required by law. (Kodjak, 10/7)

Los Angeles Times: Healthcare Costs Under Obamacare Are Not 'Going Up By Numbers That Are Astronomical' As Trump Says

Donald Trump has repeatedly claimed that the Affordable Care Act is a disaster, and did so again Sunday, noting that Americans’ monthly insurance premiums are rising by “astronomical” amounts. “Your health insurance, you’re health care, going up by numbers that are astronomical — 68%, 59%, 71%,” he said. This is a major exaggeration. (Levey and Mascaro, 10/9)

Los Angeles Times: No, Bill Clinton Didn't 'Torch' Obamacare. Here's What He Was Really Talking About

Donald Trump has repeatedly claimed over the past week that Bill Clinton “torched” the Affordable Care Act when the former president brought up the health law during a campaign rally for Hillary Clinton in Michigan on Monday. Trump was asked about his comments again again during Sunday’s debate. His claims are, at best, misleading. The former president did note that some people are still struggling to afford healthcare, despite the 2010 law, often called Obamacare. (Levey, 10/10)

The Associated Press: Fact Check: Trump Overstates Cost Of Obama's Health Plan

Trump vastly exaggerates the cost of President Barack Obama's Affordable Care Act. The cost of the coverage expansion in Obama's health care law is nowhere near what the government spends on Medicare and Medicaid, for example. (10/9)

The Associated Press: Fact Check: Trump Wrong On Clinton And Health Care

It's Vermont Sen. Bernie Sanders — not Clinton — who supports a Canada-style government-run health care system. While Clinton's health care proposals would expand the government's role in the health care system, she's not talking about dismantling the current system, which is a hybrid of employer-sponsored coverage, government programs like Medicare and Medicaid, and individually purchased insurance. (10/9)

The Associated Press: Fact Check: Clinton Correct On Repeal Of Health Care

Congressional Republicans have promised their replacement plan for Obama's health care law would provide coverage for the uninsured, but they have not provided enough detail to allow a rigorous comparison. A complete repeal of the health care law would wipe the slate clean, and lawmakers would have to start over. (10/9)

The New York Times: Can’t Find A Plan On HealthCare.Gov? One May Be Picked For You.

The federal government will choose health plans for hundreds of thousands of consumers whose insurers have left the Affordable Care Act marketplace unless those people opt out of the law’s exchanges or select plans on their own, under a new policy to make sure consumers maintain coverage in 2017. “Urgent: Your health coverage is at risk,” declares a sample “discontinuation notice,” drafted by the government for use by insurers. It tells consumers that “if you don’t enroll in a plan on your own, you may be automatically enrolled in the plan picked for you.” (Pear, 10/8)

The New York Times: How U.S. Torture Left A Legacy Of Damaged Minds

Before the United States permitted a terrifying way of interrogating prisoners, government lawyers and intelligence officials assured themselves of one crucial outcome. They knew that the methods inflicted on terrorism suspects would be painful, shocking and far beyond what the country had ever accepted. But none of it, they concluded, would cause long lasting psychological harm. Fifteen years later, it is clear they were wrong. (Apuzzo, Fink and Risen, 10/09)

The Wall Street Journal: Insulin Prices Soar While Drugmakers’ Share Stays Flat

Insulin prices are soaring, creating pain for patients whose lives depend on the injectable drug—yet most of the revenue from the increases isn’t going to the drug manufacturers. It is largely the middlemen that benefit. The major manufacturers of insulin— Eli Lilly & Co. of Indianapolis, Novo Nordisk A/S of Denmark and Sanofi SA of France—are collecting about the same or less than they did several years ago. (Roland and Loftus, 10/7)

The Associated Press: Watchdog: Staff Issues Affect Care At Reservation Hospitals

The internal watchdog of the U.S. Department of Health and Human Services says the often-substandard quality of care at hospitals serving Native Americans is the result of outdated equipment and technology, lack of resources and difficulty attracting and keeping skilled staff. (10/7)

The Washington Post: Big Soda Sponsored 96 Health Groups — A Big Conflict Of Interest, Study Says

Nearly 100 national health and medical groups — including the American Heart Association, the American Diabetes Association and the Centers for Disease Control and Prevention — enjoy sponsorships by Coca-Cola Co. or PepsiCo, according to a new study by two Boston University researchers. The report lands as the sugar industry’s supersized role in shaping — and spinning — health policy has come under increasing scrutiny. It also comes as the negative health effects of sugar and sugary drinks, including a link to rising obesity rates, are better understood. (Lauerman, 10/10)

Los Angeles Times: Massive L.A. Coroner Backlog Comes At A Price For Loved Ones Of Those Lost

It was a sweltering day in Pomona in August 2015 when Katie Dix collapsed during a rave at the Los Angeles County Fairgrounds. She went into cardiac arrest and died at a nearby hospital. Dix’s family expected that an autopsy and lab tests would take a few weeks, but as months went by they grew frustrated and angry. Her relatives would call repeatedly, only to be told: “Next month.” “It was excruciating for her parents,” said Lee Sherman, the family’s attorney. “It is horrible enough to deal with your child’s death — the reports, the speculation. They just wanted answers.” (Winton and Sewell, 10/9)

NPR: Untangling Birth Control, Hormones And Depression

When the birth control pill debuted more than 50 years ago, women wanted to know: Is it safe? There wasn't much evidence to answer that question, but women embraced the Pill as a revolutionary improvement in contraception. Today, millions of women around the world use hormonal contraceptives that have expanded beyond the Pill to patches, implants, injections and uterine devices. Decades of research support their safety, and serious but very rare side effects such as blood clots are finally much better understood. But other areas of research lag, and we still don't know as much as we'd like about how these medications affect women's mental health. (Haelle, 10/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, July 20
  • Friday, July 17
  • Thursday, July 16
  • Wednesday, July 15
  • Tuesday, July 14
  • Monday, July 13
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF